Allergy Notes, Evidence-based Information by Board-certified Physicians

Omalizumab (Xolair) linked to higher risk of heart attack, mini-stroke (TIA), blood clots - FDA changes the label

The simple, modern approach to anti-histamine resistant urticaria relies on omalizumab

Against all odds: how does anti-IgE (omalizumab) treatment affect intrinsic asthma?

What is NNT for omalizumab to prevent one hospitalization for asthma exacerbation? 33

When to discontinue SCIT? And omalizumab?

Omalizumab reduced asthma exacerbations in patients older than 50 years by 69%

Omalizumab safe and effective as add-on therapy to corticosteroids in asthma (meta-analysis)

Omalizumab (Xolair) effective against chronic idiopathic urticaria

Pretreatment with omalizumab improves tolerability of immunotherapy in allergic asthma